Global Decentralized Clinical Trials (DCTs) Market Insights and Forecast to 2028

The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model.
Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.
Market Analysis and Insights: Global Decentralized Clinical Trials (DCTs) Market
The global Decentralized Clinical Trials (DCTs) market size is projected to reach US$ 18950 million by 2028, from US$ 7135 million in 2021, at a CAGR of 14.8% during 2022-2028.
Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%.
North America is the largest production region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Decentralized Clinical Trials (DCTs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Decentralized Clinical Trials (DCTs) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Decentralized Clinical Trials (DCTs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Decentralized Clinical Trials (DCTs) market.
Global Decentralized Clinical Trials (DCTs) Scope and Market Size
Decentralized Clinical Trials (DCTs) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Decentralized Clinical Trials (DCTs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Interventional
Observational
Expanded Access
Segment by Application
Oncology
Cardiovascular
Others
By Company
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA